IP Library › Granted Patent US 6,943,161

Granted Patent B2

US 6,943,161 · App. 10/186,161 · Granted Sep 13, 2005

Pyrimidine and triazine kinase inhibitors

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 6,943,161
App. No.: 10/186,161
Granted: Sep 13, 2005
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

Compounds that selectively inhibit inappropriate kinase activities and methods for their preparation are disclosed. In one embodiment, the compounds are represented by Formula I, As selective inhibitors of inappropriate kinase activities, the compounds of the present invention are useful in the treatment of conditions associated with such activity, including, but not limited to, inflammatory and autoimmune responses, diabetes, asthma, psoriasis, inflammatory bowel disease, transplantation rejection, and tumor metastasis. Also disclosed are methods of inhibiting inappropriate kinase activities and methods of treating conditions associated with such activities.

Claims (290)

1. A compound, or a salt thereof, represented by Formula I,

wherein:

R 1 is chosen from arylalkyl, fused arylcycloalkyl, cycloalkyl(alkyl), aminocarbonylalkyl, alkoxyalkyl, substituted arylalkyl, heteroaryl other than 2-pyridinyl, heteroarylalkyl, heterocyclylalkyl, and substituted heterocyclylalkyl;

R 2 is chosen from

wherein

R 5 is chosen from H, alkyl and substituted alkyl;

R 6 is a direct bond; and

R 7 is chosen from heterocyclyl other than 2-pyridinyl and substituted heteroaryl other than 2-pyridinyl;

R 3 is chosen from a direct bond,

wherein the left hand bond is the point of attachment to the ring and the right hand bond is the point of attachment to R 1 ;

R 4 is chosen from H, halogen, alkyl, a saturated cyclic structure of from 1 to 6 carbon atoms containing from 1 to 4 heteroatoms chosen from O, N and S, a bicyclic 9- to 10-membered heteroaryl containing from 1 to 4 heteroatoms chosen from O, N and S, alkylamino, aminocarbonyl, acyl, —C(═NH)NH 2 ,

C(S)NHR 12 , CHR 13 R 14 , C(O)NHR 15 , C(O)(CH 2 ) 0-2 R 16 , S(O 2 )R 17 , OR 18 ,

wherein

R 10 is chosen from H, OH, alkyl, cycloalkyl and substituted cycloalkyl;

R 11 is chosen from H, OH, COOH, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, alkoxy, aminocarbonyl, aminocarbonylalkyl,

with the proviso that, when R 3 is a direct bond, R 11 cannot be 2-pyridinyl or substituted 2-pyridinyl;

R 12 is chosen from alkyl, cycloalkyl and aryl;

R 13 is chosen from H and aryl;

R 14 is chosen from aryl, substituted aryl, heteroaryl, substituted alkyl, aryl substituted alkyl and alkoxy substituted alkyl,

R 15 is chosen from alkyl, aryl, substituted aryl and substituted alkyl;

R 16 is chosen from aryl, substituted aryl, heteroaryl, carboxyl, alkoxy, substituted alkyl, cycloalkyl, substituted cycloalkyl, aminocarbonyl, substituted aminocarbonyl, heterocyclyl and

R 17 is chosen from alkyl and dialkylamino;

R 18 is chosen from C 1 to C 20 alkyl, substituted C 1 to C 20 alkyl; and

Y is chosen from H and lower alkyl.

2. A compound, or salt thereof, according to claim 1 , wherein:

R 1 is chosen from arylalkyl, fused arylcycloalkyl, cycloalkyl(alkyl), and substituted arylalkyl;

R 2 is

wherein

R 5 is H, and

R 7 is substituted heteroaryl;

R 3 is chosen from

and

R 4 is C(O)NHR 15 , wherein R 15 is substituted aryl.

3. A compound, or salt thereof, according to claim 1 , wherein:

R 1 is chosen from arylalkyl, fused arylcycloalkyl, cycloalkyl(alkyl), aminocarbonylalkyl, heteroarylalkyl and substituted arylalkyl;

R 2 is chosen from

wherein

R 5 is chosen from H and substituted alkyl;

R 3 is chosen from

and

R 4 is H.

4. A compound, or salt thereof, according to claim 1 , wherein:

R 2 is

wherein

R 5 is chosen from H and alkyl; and

R 7 is chosen from heterocyclyl and substituted heteroaryl;

R 3 is chosen from

and

R 4 is chosen from C(S)NHR 12 , C(O)NHR 15 and C(O)(CH 2 ) 0-2 R 16 wherein

R 12 is aryl;

R 15 is substituted aryl; and

R 16 is chosen from substituted aryl and heteroaryl.

5. A compound, or salt thereof, according to claim 1 , wherein:

R 1 is chosen from arylalkyl, fused arylcycloalkyl, cycloalkyl(alkyl), aminocarbonylalkyl, substituted arylalkyl, heteroarylalkyl, heterocyclylalkyl, and substituted heterocyclylalkyl;

R 2 is

wherein

R 5 is H; and

R 7 is chosen from heteroaryl and substituted heteroaryl;

R 3 is chosen from

and

R 4 is chosen from H and C(O)(CH 2 ) 0-2 R 16 .

6. A compound, or salt thereof, according to claim 1 , wherein:

R 1 is chosen from arylalkyl, fused arylcycloalkyl, cycloalkyl(alkyl), alkoxyalkyl, substituted arylalkyl, heteroarylalkyl, and substituted heterocyclylalkyl;

R 2 is

wherein

R 5 is chosen from H and alkyl; and

R 7 is heterocyclyl;

R 3 is chosen from a direct bond,

and

R 4 is chosen from H,

C(S)NHR 12 , CHR 13 R 14 , C(O)NHR 15 and C(O)(CH 2 ) 0-3 R 16 wherein

R 10 is H;

R 11 is H;

R 12 is alkyl;

R 13 is H;

R 14 is chosen from heteroaryl, substituted aryl and alkoxy substituted alkyl;

R 15 is chosen from aryl and substituted aryl; and

R 16 is substituted aryl.

7. A compound, or salt thereof, according to claim 1 , wherein:

R 14 is chosen from aryl, substituted aryl, heteroaryl, substituted alkyl and aryl substituted alkyl.

8. A compound, or salt thereof, according to claim 1 , wherein:

R 1 is heteroaryl;

R 2 is

R 3 is chosen from a direct bond,

and

R 4 is chosen from C(O)(CH 2 ) 0-2 R 16 and

9. A method of inhibiting kinase activity in a mammal, said method comprising administering to said mammal an effective amount of a compound according to claim 1 .

10. A method of treating a condition associated with kinase activity in a mammal, said condition chosen from angiogenesis and tumor metastasis, the method comprising administering to a mammal in need of such treatment, an effective amount of a compound according to claim 1 .

11. A pharmaceutical composition comprising as a therapeutic agent, a compound according to claim 1 and a pharmaceutically acceptable carrier.

12. A pharmaceutical composition according to claim 11 , further comprising one or more additional therapeutic agents.

13. A pharmaceutical composition according to claim 12 , wherein said one or more additional therapeutic agents are chosen from anti-inflammatory and immunosuppressive agents.

14. A pharmaceutical composition according to claim 12 , wherein said one or more additional therapeutic agents are chosen from antirheumatic, steroid, corticosteroid, NSAID, antipsoriatic, bronchodilator, antiasthmatic and antidiabetic agents.

15. A compound, or a salt thereof, represented by Formula I,

wherein:

R 2 is chosen from heteroaryl, substituted heteroaryl, heterocyclyl, substituted heterocyclyl,

R 3 is chosen from

wherein the left hand bond is the point of attachment to the ring and the right hand bond is the point of attachment to R 4 ;

C(S)NHR 12 , CHR 13 R 14 , C(O)NHR 15 , C(O)(CH 2 ) 0-2 R 16 , S(O 2 )R 17 , OR 18 ,

wherein

R 10 is chosen from H, OH, alkyl, cycloalkyl and substituted cycloalkyl;

R 11 is chosen from H, OH, COOH, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aryl substituted alkyl, cycloalkyl, substituted cycloalkyl, alkoxy, aminocarbonyl, aminocarbonylalkyl,

R 12 is chosen from alkyl, cycloalkyl and aryl;

R 13 is chosen from H and aryl;

R 14 is chosen from aryl, substituted aryl, heteroaryl, substituted alkyl, aryl, substituted alkyl and alkoxy substituted alkyl:

R 15 is chosen from alkyl, aryl, substituted aryl and substituted alkyl;

R 16 is chosen from aryl, substituted aryl, heteroaryl, carboxyl, alkoxy, substituted alkyl, cycloalkyl, substituted cycloalkyl, aminocarbonyl, substituted aminocarbonyl, heterocyclyl and

R 17 is chosen from alkyl and dialkylamino; and

R 18 is chosen from C 1 to C 20 hydrocarbon, substituted C 1 to C 20 hydrocarbon and heteroaryl; and

Y is chosen from H and lower alkyl.

16. A compound, or salt thereof, according to claim 15 wherein:

R 1 is chosen from arylalkyl, fused arylcycloalkyl, cycloalkyl(alkyl), and substituted arylalkyl; and

R 3 is chosen from

17. A compound, or salt thereof, according to claim 16 , wherein:

C(S)NHR, CHR 13 R 14 , C(O)NHR 15 , C(O)(CH 2 ) 0-2 R 16 , S(O 2 )R 17 , OR 18 ,

wherein

R 10 is chosen from H, OH, alkyl, cycloalkyl and substituted cycloalkyl;

R 11 is chosen from H, OH, COOH, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aryl substituted alkyl, cycloalkyl, substituted cycloalkyl, alkoxy, aminocarbonyl, aminocarbonylalkyl,

R 12 is chosen from alkyl and aryl;

R 13 is chosen from alkyl and aryl;

R 14 is chosen from aryl, substituted aryl, heteroaryl, substituted alkyl, aryl substituted alkyl and alkoxy substituted alkyl,

R 15 is chosen from alkyl, aryl, substituted aryl and substituted alkyl;

R 16 is chosen from aryl, substituted aryl, heteroaryl, carboxyl, alkoxy, substituted alkyl, cycloalkyl, substituted cycloalkyl, aminocarbonyl, substituted aminocarbonyl, heterocyclyl and

R 17 is chosen from alkyl and dialkylamino; and

R 18 is chosen from C 1 to C 20 hydrocarbon, substituted C 1 to C 20 hydrocarbon and heteroaryl; and

Y is chosen from H and lower alkyl.

18. A compound, or salt thereof, according to claim 1 wherein:

R 2 is chosen from

and

R 3 is a direct bond.

19. A compound, or a salt thereof, represented by Formula I,

wherein:

R 2 is chosen from heteroaryl, substituted heteroaryl, substituted heterocyclyl,

R 3 is chosen from

wherein the left hand bond is the point of attachment to the ring and the right hand bond is the point of attachment to R 1 ;

R 4 is chosen from halogen, alkyl, a saturated cyclic structure of from 1 to 6 carbon atoms containing from 1 to 4 heteroatoms chosen from O, N and S, a bicyclic 9- to 10-membered heteroaryl containing from 1 to 4 heteroatoms chosen from O, N and S, alkylamino, aminocarbonyl, acyl, —C(═NH)NH 2 ,

C(S)NHR 12 , CHR 13 R 14 , C(O)NHR 15 , C(O)(CH 2 ) 0-2 R 16 , S(O 2 )R 17 , OR 18 ,

wherein

R 10 is chosen from H, OH, alkyl, cycloalkyl and substituted cycloalkyl;

R 11 is chosen from H, OH, COOH, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aryl substituted alkyl, cycloalkyl, substituted heteroalkyl, alkoxy aminocarbonyl, aminocarbonylalkyl,

R 12 is chosen from alkyl cycloalkyl and aryl;

R 13 is chosen from H and aryl;

R 14 is chosen from aryl, substituted aryl, heteroaryl, substituted alkyl, aryl substituted alkyl and alkoxy substituted alkyl,

R 15 is chosen from alkyl, aryl, substituted aryl and substituted alkyl;

R 16 is chosen from aryl, substituted aryl, heteroaryl, carboxyl, alkoxy, substituted alkyl, cycloalkyl, substituted cycloalkyl, aminocarbonyl, substituted aminocarbonyl, heterocyclyl and

R 17 is chosen from alkyl and dialkylamino; and

R 18 is chosen from C 1 to C 20 hydrocarbon, substituted C 1 to C 20 hydrocarbon and heteroaryl; and

Y is chosen from H and lower alkyl.

20. A compound, or a salt thereof, represented by Formula I,

wherein:

R 1 is chosen from optionally substituted benzothiazolyl, quinolinyl, benzoxazolyl, benzodioxolyl and benzotriazolyl;

R 2 is chosen from halogen, C 1 to C 20 hydrocarbon, hydroxy, heteroaryl, substituted heteroaryl, heterocyclyl, and substituted heterocyclyl;

R 3 is chosen from a direct bond,

wherein the left hand bond is the point of attachment to the ring and the right hand bond is the point of attachment to R 4 ;

R 4 is chosen from H, alkyl, and OR 18

wherein

R 18 is chosen from C 1 to C 20 hydrocarbon, substituted C 1 to C 20 hydrocarbon and heteroaryl; and

Y is chosen from H and lower alkyl.

21. A compound, or a salt thereof, represented by Formula I,

wherein

R 1 is chosen from aminocarbonylalkyl, alkoxyalkyl, substituted arylalkyl, heteroaryl, heteroarylalkyl, heterocyclylalkyl, and substituted heterocyclylalkyl;

R 2 is chosen from benzimidazolyl and substituted benzimidazolyl;

R 3 is chosen from a direct bond,

wherein the left hand bond is the point of attachment to the ring and the right hand bond is the point of attachment to R 4 ;

C(S)NHR 12 , CHR 13 R 14 , C(O)NHR 15 , C(O)(CH 2 ) 0-2 R 16 , S(O 2 )R 17 , OR 18 ,

wherein

R 10 is chosen from H, OH, alkyl, cycloalkyl and substituted cycloalkyl;

R 11 is chosen from H, OH, COOH, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aryl substituted alkyl, cycloalkyl, substituted cycloalkyl, alkoxy, aminocarbonyl, aminocarbonylalkyl,

R 12 is chosen from alkyl and aryl;

R 13 is chosen from H and aryl;

R 14 is chosen from aryl, substituted aryl, heteroaryl, substituted alkyl, aryl substituted alkyl and alkoxy substituted alkyl,

R 15 is chosen from alkyl, aryl, substituted aryl and substituted alkyl;

R 16 is chosen from aryl, substituted aryl, heteroaryl, carboxyl, alkoxy, substituted alkyl, cycloalkyl, substituted cycloalkyl, aminocarbonyl, substituted aminocarbonyl, heterocyclyl and

R 17 is chosen from alkyl and dialkylamino; and

R 18 is chosen from C 1 to C 20 hydrocarbon, substituted C 1 to C 20 hydrocarbon and heteroaryl; and

Y is chosen from H and lower alkyl.

22. A compound, or salt thereof, according to claim 15 , wherein:

R 1 is chosen from arylalkyl, fused arylcycloalkyl, cycloalkyl(alkyl), aminocarbonylalkyl, heteroarylalkyl and substituted arylalkyl;

R 2 is

R 3 is

and

R 4 is H.

23. A compound, or salt thereof, according to claim 21 , wherein:

R 1 is chosen from aminocarbonylalkyl, substituted arylalkyl, heteroarylalkyl, heterocyclylalkyl, and substituted heterocyclylalkyl;

R 2 is

R 3 is chosen from

and

R 4 is chosen from H and C(O)(CH 2 ) 0-2 R 16 .

24. A compound, or salt thereof, according to claim 21 , wherein:

R 1 is chosen from arylalkyl, fused arylcycloalkyl, cycloalkyl(alkyl), alkoxyalkyl, substituted arylalkyl, heteroarylalkyl, and substituted heterocyclylalkyl;

R 2 is

R 3 is chosen from a direct bond,

and

R 4 is chosen from H,

C(S)NHR 12 , CHR 13 R 14 , C(O)NHR 15 and C(O)(CH 2 ) 0-2 R 16 wherein

R 10 is H;

R 11 is H;

R 12 is alkyl;

R 13 is H;

R 14 is chosen from heteroaryl, substituted aryl and alkoxy substituted alkyl;

R 15 is chosen from aryl and substituted aryl; and

R 16 is substituted aryl.

25. A compound, or salt thereof, according to claim 1 wherein:

R 2 is chosen from

R 3 is chosen from

R 4 is chosen from H, alkyl a saturated cyclic structure of from 1 to 6 carbon atoms containing from 1 to 4 heteroatoms chosen from O, N and S, a bicyclic 9- to 10-membered heteroaryl containing from 1 to 4 heteroatoms chosen from O, N and S, aminocarbonyl, acyl —C(═NH)NH 2 , C(S)NHR 12 , CHR 13 R 14 , C(O)NHR 15 , C(O)(CH 2 ) 0-2 16 , and S(O 2 )R 17 .

26. A compound, or salt thereof, according to claim 1

wherein:

R 1 is chosen from substituted arylalkyl, heterocyclylalkyl, and substituted heterocyclylalkyl;

R 2 is

wherein

R 5 is chosen from H, alkyl and substituted alkyl;

R 6 is a direct bond; and

R 7 is chosen from optionally substituted benzothiazolyl, quinolinyl, benzoxazolyl, benzodioxolyl and benzotriazolyl;

R 3 is chosen from a direct bond,

wherein the left hand bond is the point of attachment to the ring and the right hand bond is the point of attachment to R 4 ;

R 4 is chosen from H, halogen, alkyl, a bicyclic 9- to 10-membered heteroaryl containing from 1 to 4 heteroatoms chosen from O, N and S, alkylamino, aminocarbonyl, acyl, —C(—NH)NH 2 ,

C(S)NHR 12 , CHR 13 R 14 , C(O)NHR 15 , C(O)(CH 2 ) 0-2 R 16 , S(O)R 17 , OR 18 ,

wherein

R 10 is chosen from H, OH, alkyl, cycloalkyl and substituted cycloalkyl;

R 11 is chosen from H, OH, COOH, cycloalkyl, substituted cycloalkyl, alkoxy, aminocarbonyl, aminocarbonylalkyl,

R 12 is chosen from alkyl cycloalkyl and aryl;

R 13 is chosen from H and aryl;

R 14 is chosen from aryl, substituted aryl, heteroaryl, substituted alkyl, aryl substituted alkyl and alkoxy substituted alkyl,

R 15 is chosen from alkyl, aryl, substituted aryl and substituted alkyl;

R 16 is chosen from aryl, substituted aryl, heteroaryl, carboxyl, alkoxy, substituted alkyl, cycloalkyl, substituted cycloalkyl, aminocarbonyl, substituted aminocarbonyl, heterocyclyl and

R 17 is chosen from alkyl and dialkylamino; and

R 18 is chosen from C 1 to C 20 alkyl, substituted C 1 to C 20 alkyl; and

Y is chosen from H and lower alkyl.

27. A compound, or salt thereof, according to claim 26 , wherein

R 3 is a direct bond; and

R 4 is chosen from H, halogen, alkyl, alkylamino, and

wherein

R 10 is chosen from H, OH, alkyl, cycloalkyl and substituted cycloalkyl;

R 11 is chosen from H, OH, COOH, cycloalkyl, substituted cycloalkyl, alkoxy, aminocarbonyl, aminocarbonylalkyl,

28. A compound, or a salt thereof, represented by Formula I,

wherein:

R 1 is chosen from C 1 to C 20 hydrocarbon, alkoxyalkyl, substituted arylalkyl, heteroaryl, heteroarylalkyl, heterocyclylalkyl, and substituted heterocyclylalkyl;

R 2 is

wherein

R 5 is chosen from H, alkyl and substituted alkyl;

R 6 is a direct bond; and

R 7 is chosen from H, acyl, alkyl, and substituted alkyl;

R 3 is a direct bond;

R 4 is

wherein

R 10 is chosen from H and alkyl;

R 11 is chosen from benzothiazolyl, quinolinyl, benzoxazolyl, benzodioxolyl and benzotriazolyl; and substituted benzothiazolyl, quinolinyl, benzoxazolyl, benzodioxolyl and benzotriazolyl;

Y is chosen from H and lower alkyl.

29. A compound, or a salt thereof, represented by Formula I,

wherein

R 1 is C 1 to C 20 hydrocarbon;

R 2 is

wherein

R 5 is chosen from H, alkyl and substituted alkyl;

R 6 is a direct bond; and

R 7 is chosen from benzothiazolyl, quinolinyl, benzoxazolyl, benzodioxolyl and benzotriazolyl; and substituted benzothiazolyl, quinolinyl, benzoxazolyl, benzodioxolyl and benzotriazolyl;

R 3 is a direct bond;

R 4 is chosen from H, halogen, alkyl, aminocarbonyl, acyl, —C(—NH)NH 2 , C(S)NHR 12 , CHR 13 R 14 , C(O)NHR 15 , C(O)(CH 2 ) 0-2 R 16 , S(O 2 )R 17 , OR 18 ,

wherein

R 12 is chosen from alkyl cycloalkyl and aryl;

R 13 is chosen from H and aryl;

R 14 is chosen from aryl, substituted aryl, heteroaryl, substituted alkyl, aryl substituted alkyl and alkoxy substituted alkyl,

R 15 is chosen from alkyl, aryl, substituted aryl and substituted alkyl;

R 16 is chosen from aryl, substituted aryl, heteroaryl, carboxyl, alkoxy, substituted alkyl, cycloalkyl, substituted cycloalkyl, aminocarbonyl, substituted aminocarbonyl, heterocyclyl and

R 17 is chosen from alkyl and dialkylamino; and

R 18 is chosen from C 1 to C 20 alkyl, substituted C 1 to C 20 alkyl; and

Y is chosen from H and lower alkyl.

30. A compound, or a salt thereof, represented by Formula XX, XXI or XXII,

wherein

R 5 is chosen from H, alkyl and substituted alkyl;

R 7 is chosen from aryl, substituted aryl, heterocyclyl, heteroaryl, and substituted heteroaryl;

R 3 is chosen from a direct bond,

wherein the left hand bond is the point of attachment to the ring and the right hand bond is the point of attachment to R 4 ;

C(S)NHR 12 , CHR 13 R 14 , C(O)NHR 15 , C(O)(CH 2 ) 0-2 R 16 , S(O 2 )R 17 , OR 18 ,

wherein

R 10 is chosen from H, OH, alkyl, cycloalkyl and substituted cycloalkyl;

R 11 is chosen from H, OH, COOH, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, alkoxy, aminocarbonyl, aminocarbonylalkyl,

R 12 is chosen from alkyl cycloalkyl and aryl;

R 13 is chosen from H and aryl;

R 14 is chosen from aryl, substituted aryl, heteroaryl, substituted alkyl, aryl substituted alkyl and alkoxy substituted alkyl,

R 15 is chosen from alkyl, aryl, substituted aryl and substituted alkyl;

R 16 is chosen from aryl, substituted aryl, heteroaryl, carboxyl, alkoxy, substituted alkyl, cycloalkyl, substituted cycloalkyl, aminocarbonyl, substituted aminocarbonyl, hctcrocylyl and

R 17 is chosen from alkyl and dialkylamino; and

R 18 is chosen from C 1 to C 20 alkyl, substituted C 1 to C 20 alkyl.